Submitted by Ricardo Cedraz Duque Moliterno (ricardo.moliterno@uefs.br) on 2017-10-05T21:58:20Z No. of bitstreams: 1 TESE- MARIA MAIANY DE OLIVEIRA.pdf: 1486275 bytes, checksum: 077fcda867394bf1737e7758d79af6a2 (MD5) / Made available in DSpace on 2017-10-05T21:58:20Z (GMT). No. of bitstreams: 1 TESE- MARIA MAIANY DE OLIVEIRA.pdf: 1486275 bytes, checksum: 077fcda867394bf1737e7758d79af6a2 (MD5) Previous issue date: 2017-03-29 / Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior - CAPES / Banana (Musa spp.) is considered one of the most important fruits in world trade due to its nutritional and economic potential.But although there is a large number varieties on the market, the banana is still affected by many diseases.The application of the method of crosses in this species is very difficult because the majority of cultivated varieties is triploid presenting low fertility. In this case, it is necessary to use biotechnology and its tools applied to non-conventional genetic improvement to develop new varieties that have resistance to their different types of pathogens.This work was carried out with the objective of adapting the technique of obtaining embryogeniccallus of banana by means of the Scalp method in cultivars Brazilian Ma?? and Pacovan, adjusting the processes of induction of meristematic structures and multiplication of shoots and induce increased genetic variability by in vitro mutagenesis using the chemical agent ethylmethanesulfonate and, of the genetic transformation by the bombardment of microparticles. Was evaluated the callus formation, the effect of mutagenic in the in vitro cultivation of shoots and the effects of genetic transformation on shoot resistance in selection medium containing the herbicide Imazapyr. The results showed that the merystematic structures obtained have the capacity to origin callus with only one month of cultivation, and both cultivars developed friable callus with average values above 90%.The efficiency of this method was evidenced by the high capacity of induction of friable callus in the two evaluated cultivars but also by the rapidity in the process of obtaining calluses, being the first study of adaptation of the methodology for Brazilian banana cultivars.On the other hand, the evaluation of the mutation induction allowed to conclude that the survival and the capacity of bud formation decreased as a function of the increase of the concentration and the immersion time in the ethylmethanesulfonate.The surviving plants underwent a sorting with the fusaric acid selective agent in which it was possible to regenerate in vitro plants of the cultivars submitted to treatment with the mutagen and to select possible mutants with fusaric acid resistance for cultivarsMa?? and Pacovan.And the genetic transformation method proved efficient in the regeneration of shoots resulting in high values of survival and multiplication, where possible transgenic plants of banana cv. Ma?? were obtained after selection of resistance to the herbicide.Therefore, it is concluded that all the material produced, both in the mutagenic phase and in the genetic transformation, presents a greater genetic variability potentially applicable to the banana improvement. / A banana (Musa spp.) ? considerada um dos mais importantes frutos no com?rcio mundial em virtude seu potencial nutritivo e econ?mico. Mas, apesar de existir um grande n?mero de variedades no mercado, a bananeira ainda ? acometida por muitas doen?as. A aplica??o do m?todo de cruzamentos nesta esp?cie ? muito dif?cil, pois a maioria das variedades cultivadas ? triploide apresentando baixa fertilidade. Nesse caso, faz-se necess?rio o uso da biotecnologia e de suas ferramentas aplicadas ao melhoramento gen?tico n?o convencional para desenvolver novas variedades que tenham resist?ncia aos seus diferentes tipos de pat?genos. Este trabalho foi realizado com os objetivos de adaptar a t?cnica de obten??o de calos embriog?nicos de bananeira por meio do m?todo Scalp nas cvs. Ma?? e Pacovan, ajustando os processos de indu??o de estruturas polimeristem?ticas ede multiplica??o de brotos e induzir o aumento da variabilidade gen?tica por meio da mutag?nese in vitro com o uso do agente qu?mico etilmetanosulfonato e, da transforma??o gen?tica pelo bombardeamento de micropart?culas.Foram avaliados os calos formados, o efeito do mutag?nico no cultivo in vitro de brotos e, os efeitos da transforma??o gen?tica quanto ? resist?ncia dos brotos em meio de sele??o contendo o herbicida Imazapyr. Os resultados mostraram que as estruturas polimeristem?ticas obtidas t?m capacidade de originar calos com apenas um m?s de cultivo e, ambas as cultivares desenvolveram calos fri?veis com rendimentos m?dios acima de 90%. A efici?ncia desse m?todo foi comprovada pela alta capacidade de indu??o de calos fri?veis nas duas cultivares avaliadas, como tamb?m pela rapidez no processo de obten??o de calos, sendo este o primeiro estudo de adapta??o da metodologia para as cultivares Ma?? e Pacovan. Por outro lado, a avalia??o da indu??o de muta??o permitiu concluir que a sobreviv?ncia e a capacidade de forma??o de brotos diminu?ram em fun??o do aumento da concentra??o e do tempo de imers?o no etilmetanosulfonato. As plantas sobreviventes passaram por uma triagem com o agente seletivo ?cido fus?rico na qual, foi poss?vel regenerar plantas in vitro das cultivares submetidas ao tratamento com o mutag?nico e selecionar poss?veis mutantes com resist?ncia ao ?cido fus?rico para as cvs. Ma?? e Pacovan. O m?todo da transforma??o gen?tica mostrou-se eficiente na regenera??o dos brotos resultando em altos valores de sobreviv?ncia e multiplica??o, onde poss?veis plantas transg?nicas de bananeira cv. Ma?? foram obtidas, ap?s a sele??o de resist?ncia ao herbicida. Portanto, conclui-se que todo material produzido, tanto na fase mutag?nica quanto na transforma??o gen?tica, apresenta uma maior variabilidade gen?tica potencialmente aplic?vel ao melhoramento da bananeira.

Made available in DSpace on 2014-12-17T14:16:25Z (GMT). No. of bitstreams: 1 ZamaMLS_DISSERT.pdf: 2983727 bytes, checksum: 7afd93b3940a02c3ef820577c21fb808 (MD5) Previous issue date: 2010-02-25 / Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior / Beta thalassemia arises as a consequence of the reduction (?+, ?++, ?silent) or absence (?0) of beta globin chain synthesis and results from a number of mechanisms that lead to genetic defects. The inheritance of beta thalassemia is characterized by the existence of heterozygous individuals, compound heterozygotes, homozygotes and those with coinheritance of beta thalassemia allele and other thalassemias and/or hemoglobin variants. The aim of this study was to perform molecular and laboratory characterization of beta thalassemia in heterozygous and homozygous individuals and in those with coinheritance of S beta thalassemia. A total of 48 individuals were included (35 heterozygotes, 4 homozygotes and 9 S beta thalessemia carriers) referred to the Integrated Laboratory of Clinical Analyses of the Federal University of Rio Grande do Norte (UFRN) and the Hematology Ambulatory Facility of the Dalton Barbosa Cunha Hemocenter (Hemonorte Natal, Brazil). Peripheral blood samples form each patient underwent the following laboratory examinations: erythrogram, hemoglobin electrophoresis at alkaline pH, measurements of Hb A2, Fetal Hb and serum ferritin. DNA was extracted using the illustra blood genomicPrep Mini Spin Kit and molecular characterization was performed by the PCR/RFLP technique, which involves digestion with specific restriction enzymes for IVS-1 nt 1 (G?A), IVS-1 nt 6 (T?C) and codon 39 (CAG?TAG) mutations. Of the 35 heterozygotes, 37.1% showed IVS-1 nt 6 mutation, 42.9% IVS-1 nt 1 and 20% were carriers of other mutations not identified by the technique used. The four homozygous patients presented with the IVS-1 nt 6 mutation, while 66.7% of the individuals with S beta thalassemia had the IVS-1 nt 1 mutation. Codon 39 was not detected in any of the patients investigated. Of the thallasemic alleles found, 40.4% were IVS- 1 nt 1, 40.4% IVS-1 nt 6 and 19.2% were not identified. Laboratory data showed that the heterozygotes exhibited microcytosis and hypochromia, evidenced by MCV ranging from 57 to 75fL and MCH from 15.9 to 23.6 pg. Hemoglobin A2 varied between 3.7 and 7.2%. The homogygotes also showed reduced MCV and MCH and elevated HbA2.. Comparison of laboratory data between heterozygous individuals with IVS-1 nt 1 and IVS-1 nt 6 mutations showed that heterozygotes for the IVS1-1 mutation had significantly lower mean MCV and MCH (p = 0.023 and 0.007, respectively) and significantly higher hemoglobin A2 (p < 0.001) when compared to heterozygotes for the IVS-1 nt 6 mutation. PCR/RFLP was useful in identifying the presence or absence of IVS-1 nt 6, IVS-1 nt 1 and codon 39 mutations in most of the patients investigated here. This is the first study conducted in the state of Rio Grande do Norte, Brazil aimed at identifying beta thalassemia mutations and represents an important contribution to the knowledge regarding the molecular profile of beta thalassemia in our country / A talassemia beta ocorre devido ? diminui??o (?+, ?++, ?silent) ou aus?ncia (?0) de s?ntese de cadeias beta de globina e ? decorrente de v?rios mecanismos que provocam o defeito gen?tico. A heran?a da talassemia beta ? caracterizada pela exist?ncia de indiv?duos heterozigotos, heterozigoto compostos, homozigotos e portadores de intera??o entre o alelo talass?mico beta e outras talassemias e/ou variantes de hemoglobina. O objetivo principal deste estudo foi realizar a caracteriza??o molecular e laboratorial em indiv?duos heterozigotos e homozigotos da talassemia beta e em portadores da intera??o hemoglobina S/talassemia beta. Foram inclu?dos 48 indiv?duos (35 heterozigotos, 4 homozigotos e 9 com intera??o HbS/talassemia beta) atendidos no Laborat?rio Integrado de An?lises Cl?nicas (UFRN) e no Ambulat?rio de Hematologia do Hemocentro Dalton Barbosa Cunha (Hemonorte Natal/RN). As amostras de sangue perif?rico de cada paciente foram submetidas aos seguintes exames laboratoriais: eritrograma, eletroforese de hemoglobina em pH alcalino, dosagem das hemoglobinas A2 e Fetal, e ferritina s?rica. O DNA foi extra?do utilizando-se o kit blood genomicPrep Mini Spin e a caracteriza??o molecular foi realizada atrav?s da t?cnica PCR/RFLP mediante digest?o com enzimas de restri??o espec?ficas para as muta??es IVS-1 nt 1 (G?A), IVS-1 nt 6 (T?C) e nonsense c?don 39 (CAG?TAG). Dentre os 35 heterozigotos, 37,1% apresentaram a muta??o IVS-1 nt 6, 42,9% a IVS-1 nt 1 e 20% eram portadores de outras muta??es n?o identificadas com a t?cnica utilizada. Os quatro pacientes homozigotos apresentaram a muta??o IVS-1 nt 6, enquanto 66,7% dos indiv?duos com intera??o HbS/talassemia beta tinham a muta??o IVS-1 nt 1. A c?don 39 n?o foi detectada em nenhum dos pacientes investigados. Dentre os alelos talass?micos encontrados, 40,4% eram IVS-1 nt 1, 40,4% eram IVS-1 nt 6 e 19,2% n?o foram identificados. Em rela??o aos dados laboratoriais, os heterozigotos apresentaram microcitose e hipocromia evidenciada pelo VCM variando de 57 a 75fL, e o HCM, entre 15,9 a 23,6 pg. A hemoglobina A2 variou de 3,7 a 7,2%. Os homozigotos tamb?m apresentaram VCM e HCM reduzidos e HbA2 elevada. Ao comparar os dados laboratoriais entre os indiv?duos heterozigotos para as muta??es IVS-1 nt 1 e IVS-1 nt 6 observou-se que os heterozigotos da muta??o IVS1-1 apresentaram valores m?dios de VCM e HCM significativamente menores (p = 0,023 e 0,007, respectivamente) e hemoglobina A2 significativamente mais elevados (p < 0,001) quando comparados aos heterozigotos da muta??o IVS-1 nt 6. A t?cnica de PCR/RFLP se mostrou ?til para a identifica??o da presen?a ou aus?ncia das muta??es IVS-1 nt 6, IVS-1 nt 1 e ?0 c?don 39 na maioria dos pacientes investigados na pesquisa. O presente estudo ? o primeiro trabalho realizado no estado do Rio Grande do Norte para identifica??o das muta??es da talassemia beta, e constitui importante contribui??o para o conhecimento do perfil molecular da talassemia beta em nosso pa?s

Made available in DSpace on 2014-12-17T14:27:27Z (GMT). No. of bitstreams: 1 SealtielDO_DISSERT.pdf: 3399268 bytes, checksum: 1a83565dd029a077e85e5685d4a39607 (MD5) Previous issue date: 2013-08-30 / The independence of the United States and the revolutions that emerged in Europe in the eighteenth century led to the birth of the written constitution, with a mission to limit the power of the State and to ensure fundamental rights to citizens. Thus, the Constitution has become the norm and ultimate founding of the State. Because of this superiority felt the need to protect her, emerging from that constitutional jurisdiction, taking control of constitutionality of provisions his main instrument. In Brazil, the constitutionality control began with the Constitution of 1891, when "imported" the American model, which is named after incidental diffuse model of judicial review. Indeed, allowed that any judge or court could declare the unconstitutionality of the law or normative act in a concrete case. However, the Brazilian Constituent did not bring the U.S. Institute of stare decisis, by which the precedents of higher courts eventually link the below. Because of this lack, each tribunal Brazilian freely decide about the constitutionality of a rule, so that the decision took effect only between the parties to the dispute. This prompted the emergence of conflicting decisions between judicantes organs, which ultimately undermine legal certainty and the image of the judiciary. As a solution to the problem, was incorporated from the 1934 Constitution to rule that the Senate would suspend the law declared unconstitutional by the Supreme Court. With the introduction of abstract control of constitutionality, since 1965, the Supreme Court went on to also have the power to declare the invalidity of the provision unconstitutional, effectively against all without the need for the participation of the Senate. However, it remained the view that in case the Supreme Court declared the unconstitutionality of the fuzzy control law by the Senate would continue with the competence to suspend the law unconstitutional, thus the decision of the Praetorium Exalted restricted parties. The 1988 Constitution strengthened the abstract control expanding legitimized the Declaratory Action of Unconstitutionality and creating new mechanisms of abstract control. Adding to this, the Constitutional Amendment. No. 45/2004 brought the requirement of general repercussion and created the Office of Binding Precedent, both to be applied by the Supreme Court judgments in individual cases, thus causing an approximation between the control abstract and concrete constitutional. Saw themselves so that the Supreme Court, to be the guardian of the Constitution, its action should be directed to the trial of issues of public interest. In this new reality, it becomes more necessary the participation of the Senate to the law declared unconstitutional in fuzzy control by the Supreme Court can reach everyone, because such an interpretation has become obsolete. So, to adapt it to this reality, such a rule must be read in the sense that the Senate give publicity to the law declared unconstitutional by the Supreme Court, since mutated constitutional / A independ?ncia dos Estados Unidos e as revolu??es surgidas na Europa no s?culo XVIII propiciaram o nascimento da Constitui??o escrita, com a miss?o de limitar o poder do Estado e assegurar direitos fundamentais aos cidad?os. Assim, a Constitui??o tornou-se a norma fundante e suprema do Estado. Em raz?o dessa superioridade sentiu-se a necessidade de proteg?-la, surgindo a partir da? a jurisdi??o constitucional, tendo no controle de constitucionalidade de normas o seu principal instrumento. No Brasil, o controle de constitucionalidade iniciou-se com a Constitui??o de 1891, quando se importou o modelo americano, que recebeu o nome de modelo difuso incidental de controle de constitucionalidade. Com efeito, permitiu-se que qualquer juiz ou tribunal poderia declarar a inconstitucionalidade de lei ou ato normativo em um caso concreto. Entretanto, o constituinte brasileiro n?o trouxe dos Estados Unidos o instituto do stare decisis, atrav?s do qual os precedentes dos ?rg?os judiciais superiores acabam por vincular os inferiores. Em raz?o dessa aus?ncia, cada juiz ou tribunal brasileiro decidia livremente a respeito da constitucionalidade de norma, de tal maneira que a decis?o s? produzia efeitos entre as parte do lit?gio. Isso levou o surgimento de decis?es contradit?rias entre os ?rg?os judicantes, o que acabou por abalar a seguran?a jur?dica e a imagem do Judici?rio. Como sa?da para o problema, incorporou-se a partir da Constitui??o de 1934 a regra segundo a qual o Senado poderia suspender a lei declarada inconstitucional pelo Supremo Tribunal Federal. Com a introdu??o do controle abstrato de constitucionalidade, a partir de 1965, o Supremo Tribunal Federal passou a ter, tamb?m, o poder de declarar a invalidade da norma inconstitucional, com efic?cia contra todos, sem a necessidade de participa??o do Senado. Por?m, permaneceu a concep??o de que na hip?tese de o Supremo Tribunal Federal declarar a inconstitucionalidade de lei atrav?s do controle difuso o Senado continuaria com a compet?ncia de suspender a lei inconstitucional, ficando a decis?o do Pret?rio Excelso restrito ?s partes. A Constitui??o de 1988 fortaleceu o controle abstrato ampliando os legitimados da A??o Direta de Inconstitucionalidade e criando novos mecanismos de controle abstrato. Somando-se a isso, a Emenda Constitucional n.? 45/2004 trouxe o requisito da repercuss?o geral e introduziu o instituto da S?mula Vinculante, ambos para serem aplicados pelo Supremo Tribunal Federal nos julgamentos dos casos concretos, provocando consequentemente uma aproxima??o entre os controles abstrato e concreto de constitucionalidade. Enxergou-se destarte que o Supremo Tribunal Federal, como guardi?o da Constitui??o, deveria ter a sua atua??o pautada para o julgamento de quest?es de interesse p?blico. Nesta nova realidade ? desnecess?ria a participa??o do Senado para que a lei declarada inconstitucional no controle difuso pelo Supremo Tribunal Federal possa alcan?ar a todos, pois, tal interpreta??o tornou-se obsoleta. Por conseguinte, para adequ?-la a essa realidade, tal regra deve ser lida no sentido de que o Senado dar? publicidade ? lei declarada inconstitucional pelo Supremo Tribunal Federal, vez que sofreu muta??o constitucional

Submitted by Automa??o e Estat?stica (sst@bczm.ufrn.br) on 2017-04-17T23:12:48Z No. of bitstreams: 1 AnaRafaelaDeSouzaTimoteo_TESE.pdf: 3659954 bytes, checksum: d2c8b061166b6be5547b4452cf6fed7b (MD5) / Approved for entry into archive by Arlan Eloi Leite Silva (eloihistoriador@yahoo.com.br) on 2017-04-20T21:54:51Z (GMT) No. of bitstreams: 1 AnaRafaelaDeSouzaTimoteo_TESE.pdf: 3659954 bytes, checksum: d2c8b061166b6be5547b4452cf6fed7b (MD5) / Made available in DSpace on 2017-04-20T21:54:51Z (GMT). No. of bitstreams: 1 AnaRafaelaDeSouzaTimoteo_TESE.pdf: 3659954 bytes, checksum: d2c8b061166b6be5547b4452cf6fed7b (MD5) Previous issue date: 2016-12-12 / A S?ndrome de c?ncer de mama e ov?rio heredit?rio corresponde a 10-15% de todos os casos diagnosticados de c?ncer de mama no mundo. A maioria das muta??es germinativas s?o identificadas nos genes BRCA1 e BRCA2, contudo, a aplica??o de pain?is multig?nicos tem aumentado o n?mero de variantes patog?nicas detectadas em outros genes supressores de tumor. De acordo com a vers?o atual do protocolo americano NCCN (National Comprehensive Cancer Network), as muta??es em BRCA1 e BRCA2, TP53 e PTEN conferem alto risco de desenvolver c?ncer de mama, e muta??es em CDH1, CHEK2, PALB2, ATM e BRIP podem aumentar em 20% o risco para o desenvolvimento desta doen?a. Neste estudo foram analisados 157 indiv?duos com hist?rico pessoal e/ou familiar de c?ncer de mama. O DNA gen?mico foi isolado a partir de sangue perif?rico por meio de extra??o ? base de solu??o salina e as amostras foram analisadas usando o sequenciamento de nova gera??o (NGS). Foram identificadas 15 variantes patog?nicas e 4 VUS (Variants of Uncertain Significance) em 27 indiv?duos (27/157; 17%), dos quais tr?s s?o assintom?ticos. Foram identificadas sete novas variantes em 4 genes: BRCA1_c.3409A>G; BRCA2_g.26826_30318del, BRCA2_c.5800C>T; BRCA2_c.5228G>A; BRCA2_c.5305delG; ATM_c.634delT e ATR_c.3043C>T. Sessenta e oito por cento (13/19; 68%) de variantes foi detectada nos genes BRCA1 e BRCA2, enquanto 32% (6/19) foram identificados nos genes de risco moderado ATM (2/19); ATR (1/19); CDH1 (1/19); MLH1 (1/19) e MSH6 (1/19). Os indiv?duos foram separados em dois grupos para a an?lise comparativa: portadores de muta??o nos genes de alto risco e nos genes de risco moderado. Entre os tr?s indiv?duos assintom?ticos, duas variantes est?o presentes nos genes de risco moderado ATM e MLH1. Entre os indiv?duos com c?ncer de mama, dezoito pacientes (18/24; 75%) apresentaram muta??es em genes de alto risco, enquanto seis (6/24; 25%) s?o portadores de muta??es em genes de risco moderado. Ambos os grupos apresentaram alta incid?ncia de c?ncer de mama precocemente (83% dos indiv?duos). O grupo de portadores de muta??o nos genes de alto risco apresentaram maior ocorr?ncia de tumores de alto grau (83% vs 67%, P = 0,0090). No grupo de indiv?duos com muta??es em genes de risco moderado, os tumores apresentaram um fen?tipo mais agressivo com c?ncer bilateral (33% versus 11%, P = 0,0002), ocorr?ncia de met?stases (33% vs 5,6%, P <0,0001) e ?bito (33% vs 5,6%, P <0,0001). Ao todo, 1/3 de variantes foram identificadas em genes de risco moderado em pacientes com c?ncer mais agressivo. Estes resultados refor?am a import?ncia da aplica??o de an?lise multig?nica em indiv?duos em situa??o de risco para c?ncer de mama, especialmente em uma popula??o heterog?nea como brasileira. / Hereditary breast and ovarian cancer (HBOC) corresponds to 10-15% of all diagnosed cases of breast cancer in the world. The majority germline mutations are identified in BRCA1 and BRCA2 genes, however the application of multigene panels has increased the number of pathogenic variations detected in DNA repair genes. According to the current version of NCCN (National Comprehensive Cancer Network) Guideline, mutations in BRCA1, BRCA2, TP53 and PTEN confers high risk to develop breast cancer, and mutations in CDH1, CHEK2, PALB2, ATM and BRIP can increases over than 20% this risk. We analyzed 157 individuals with personal and/or familial breast cancer history. Genomic DNA was isolated from peripheral blood through saline-based extraction and samples were analyzed using next-generation sequencing (NGS). We identified 15 pathogenic variants and 4 VUS (Variants of Uncertain Significance) in 27 individuals (27/157; 17%), in which three are asymptomatic. Seven novel variants in 4 genes were identified: BRCA1_c.3409A>G; BRCA2_g.26826_30318del, BRCA2_c.5800C>T; BRCA2_c.5228G>A; BRCA2_c.5305delG; ATM_c.634delT and ATR_c.3043C>T. Sixty-eight percent (13/19; 68%) of variants was detected in BRCA1 and BRCA2 genes, while 32% (6/19) were identified in moderate risk genes ATM (2/19); ATR (1/19); CDH1 (1/19); MLH1 (1/19) and MSH6 (1/19). The individuals were separated in two groups for comparative analysis: high-risk genes and moderate risk genes. Among three asymptomatic individuals, two present variants in moderate risk genes ATM and MLH1. Among breast cancer individuals, eighteen patients (18/24; 75%) presented mutations in high-risk genes, while six (6/24; 25%) harbored mutations in moderate risk genes. Both groups had a high incidence of early-onset breast cancer, 83%. The group of individuals harboring variants in high-risk genes presented a greater occurrence of high-grade tumors (83% vs. 67%, P= 0.0090). In the group of individuals harboring mutation in moderate risk genes, tumors presented a more aggressive phenotype with bilateral cancer (33% vs. 11%, P= 0.0002), occurrence of metastasis (33% vs. 5.6%, P<0.0001) and incidence of deaths (33% vs. 5.6%, P<0.0001). Altogether, 1/3 of variants were identified in moderate risk genes in patients presenting a more aggressive phenotype. These results reinforce the importance of applying multigene analysis in individuals at-risk for breast cancer, especially in a heterogeneous population as Brazilian.

This thesis examines the interpretive tradition of Mullā Ṣadrā in the context of the schools of Tehran and Qum. Mullā Ṣadrā’s transcendental philosophy (al-ḥikmah al-mutaʿālīyah or ḥikmat) avails itself to a number of readings; however, this thesis focuses on the philosophical and mystical (ʿirfānī) readings in terms of their development, transmission and their impact on how ḥikmat is understood in the modern Iranian seminary (ḥawza). The way in which a text is read in the ḥawza has great implications for the development of ideas, as the ḥawza uses a text based system to train students in a particular field. While both readings were studied by the majority of transcendental philosophers (ḥukamāʾ) in the school of Tehran, the school of Qum saw a greater separation between the readings and I show that for a number of reasons, including the introduction of seminal texts written by ʿAllāmah Ṭabāṭabāʾī, a preference developed for a more philosophical reading of transcendental philosophy. I examine evidence for the different preferences of the ḥukamāʾ for either a more philosophical or ʿirfānī reading of ḥikmat through an examination of their writings on the subjects of existence (wujūd), guardianship (walāyah) and resurrection (maʿād) which act as case studies. The theoretical implications of both approaches are examined in each chapter as well as their interdependence. The schools of Tehran and Qum built on Mullā Ṣadrā’s framework and provided new interpretations of important issues. Apart from the intricate discussions on the core aspects of ḥikmat, Muḥammad Riżā Qumshihī’s masterful examination of the Seal of the Saints and ʿAlī Mudarris Zunūzī’s philosophy of bodily resurrection are examples of a thriving interpretive tradition in Iran and constitute significant developments of important philosophical and ʿirfānī concepts from the ideas of their predecessors.

No description available.

L'activació sostinguda de Hog1 porta a una inhibició del creixement cel·lular. En aquest treball, hem observat que el fenotip de letalitat causat per l'activació sostinguda de Hog1 és parcialment inhibida per la mutació del complexe SCFCDC4. La inhibició de la mort causada per l'activació sostinguda de Hog1 depèn de la via d'extensió de la vida. Quan Hog1 s'activa de manera sostinguda, la mutació al complexe SCFCDC4 fa que augmenti l'expressió gènica depenent de Msn2 i Msn4 que condueix a una sobreexpressió del gen PNC1 i a una hiperactivació de la deacetilassa Sir2. La hiperactivació de Sir2 és capaç d'inhibir la mort causada per l'activació sostinguda de Hog1. També hem observat que la mort cel·lular causada per l'activació sostinguda de Hog1 és deguda a una inducció d'apoptosi. L'apoptosi induïda per Hog1 és inhibida per la mutació al complexe SCFCDC4. Per tant, la via d'extensió de la vida és capaç de prevenir l'apoptosi a través d'un mecanisme desconegut. / Sustained Hog1 activation leads to an inhibition of cell growth. In this work, we have observed that the lethal phenotype caused by sustained Hog1 activation is prevented by SCFCDC4 mutants. The prevention of Hog1-induced cell death by SCFCDC4 mutation depends on the lifespan extension pathway. Upon sustained Hog1 activation, SCFCDC4 mutation increases Msn2 and Msn4 dependent gene expression that leads to a PNC1 overexpression and a Sir2 deacetylase hyperactivation. Then, hyperactivation of Sir2 is able to prevent cell death caused by sustained Hog1 activation. We have also observed that cell death upon sustained Hog1 activation is due to an induction of apoptosis. The apoptosis induced by Hog1 is decreased by SCFCDC4 mutation. Therefore, lifespan extension pathway is able to prevent apoptosis by an unknown mechanism.